Dr. med. Franjo Grotenhermen
Franjo Grotenhermen completed his studies in medicine and obtained his doctorate. med. in Cologne. His fields of activity included internal medicine, surgery and naturopathic treatments. He runs a medical practice in Steinheim (Westphalia) with a focus on therapy with cannabis and cannabinoids. Grotenhermen is the managing director of the Arbeitsgemeinschaft Cannabis als Medizin e.V. (ACM), managing director of the International Working Group for Cannabinoid Medicines (IACM) and author of the IACM information, which has been published every fortnight for more than 20 years in several languages on the IACM website. Grotenhermen is an employee of the Cologne nova Institute, co-owner of Endoxo GmbH (founded in 2019) and Head of Scientific Committee of MYCB1 (since 2019). He received the following awards: Cannabusiness hemp prize 1999, IACM 2011 Special Award, ICBC 2018 Lifetime Achievement Award, Robert Newman Memorial Prize 2018 from Accept e.V.
- Choosing a selection results in a full page refresh.
- Press the space key then arrow keys to make a selection.